"I would welcome anyone's analysis or speculation of what other reasons might explain this strange divergence in getting BP support."

The biggest reason is that Zenith deals in the treatment of multiple cancers and that attracts BP. Resverlogix does not.

We keep dumping on Don and rightly so, him being the CEO. But we can't say that the board members have not been sitting on their hands. The entire board of directors makes decisions affecting the future of the company.

Koo